drugset / Trial / NCT07566130
A Study to Assess Adverse Events, Tolerability and How Single and Ascending Oral Doses of Nacresertib Move Through the Body In Healthy Adult Participants
RandomizedParallel-groupTriple-blindBasic science
Summary
The objectives for this 2 Part study are to assess the safety, tolerability, and pharmacokinetics following single ascending oral doses of nacresertib in healthy adult participants (Part 1) and to assess the safety, tolerability, and pharmacokinetics following multiple ascending oral doses in healthy adult participants (Part 2).
Timeline
- Start
- 2025-04-18
- Primary completion
- 2026-05-07
- Completion
- 2026-05-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nacresertib | Small molecule | — | Oral |
Indications
No indication recorded.